Sponsored
Get Offer !0%
JeplusHealthcare.Pvt.Ltd
Pharma Tech
Outsourcing gap widens: Europe pulls away from US in new drug manufacturing
The industry looks set to continue a preference for European outsourcing facilities as national tax systems exert influence.
Read Full Article
Pharma Tech
Ipsen bolsters rare disease pipeline in €700m Memo takeover
Ipsen’s Memo acquisition is the second the former has signed this week alone, following its blockbuster Kartos buyout on 29 June.
Read Full Article
Pharma Tech
Podcast: HLTH Europe and BIO key trends rundown
Our editorial team delve into the key takeaways from the 2026 HLTH Europe conference and the 2026 BIO International Convention.
Read Full Article
Pharma Tech
FDA widens Vertex’s Casgevy use for paediatric patients
Children as young as two with either sickle cell disease or thalassemia are now eligible for the gene therapy.
Read Full Article
Pharma Tech
Insilico Medicine, Takeda partner on AI-driven drug discovery
Insilico Medicine has entered into a strategic collaboration agreement with Takeda to deploy its AI-based Pharma.AI platform in the discovery and development of drug candidates.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Jul 3, 2026, 6:30 AM
AlzeCure Partners with QuantumCell for NeuroRestore ACD856 in a Deal Worth up to $2.2B
Shots: Ref: AlzeCure  |  Image: AlzeCure & QuantumCell | Press Release Related News: Insilico Medicine Collaborates with Takeda to Advance AI Drug Discovery PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post AlzeCure Partners with QuantumCell for NeuroRestore ACD856 in a Deal Worth up to $2.2B appeared first on PharmaShots.
Pharma Tech
Jul 2, 2026, 2:14 PM
Outsourcing gap widens: Europe pulls away from US in new drug manufacturing
The industry looks set to continue a preference for European outsourcing facilities as national tax systems exert influence.
PharmaShots
Jul 2, 2026, 2:00 PM
Q2 in Review: Pharma’s Dealmaking Surge, a Wave of FDA Approvals, and AI’s Deepening FootprintÂ
A PharmaShots Quarterly Analysis Q2 was one of the most active quarters in recent memory for the pharmaceutical and biotech industry. Big Pharma leaned hard into M&A and licensing to refill pipelines, the FDA cleared a broad slate of new therapies, and AI-native partnerships continued to reshape how drugs get discovered. Below, we break down the quarter… The post Q2 in Review: Pharma’s Dealmaking Surge, a Wave of FDA Approvals, and AI’s Deepening Footprint appeared first on PharmaShots.
PharmaShots
Jul 2, 2026, 12:30 PM
Inocras and AimedBio Collaborate on Precision Oncology and ADC Development
Shots: Ref: Businesswire |  Image: Inocras & AimedBio | Press Release Related News: Junshi Biosciences Licenses Roconkibart to Fosun Wanbang in Greater China PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Inocras and AimedBio Collaborate on Precision Oncology and ADC Development appeared first on PharmaShots.
Pharma Tech
Jul 2, 2026, 12:19 PM
Ipsen bolsters rare disease pipeline in €700m Memo takeover
Ipsen’s Memo acquisition is the second the former has signed this week alone, following its blockbuster Kartos buyout on 29 June.
PharmaShots
Jul 2, 2026, 11:30 AM
HUTCHMED Reports NMPA Conditional Approval of Orpathys (Savolitinib) for Gastric Cancer Patients with MET Amplification
Shots: Ref: Globenewswire |  Image: HUTCHMED | Press Release Related News: HUTCHMED Reports the P-II/III (ESLIM-02) Trial Data on Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia at EHA 2026 PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post HUTCHMED Reports NMPA Conditional Approval of Orpathys (Savolitinib) for Gastric Cancer Patients with MET Amplification appeared first on PharmaShots.
News
Latest industry coverage
Google News
Jul 3, 2026, 6:19 AM
Global Biotech M&A Shows Signs of Recovery, Clinical Data and Efficacy Emerge as Key Deal-Breakers - geneonline.com
Global Biotech M&A Shows Signs of Recovery, Clinical Data and Efficacy Emerge as Key Deal-Breakers  geneonline.com
Google News
Jul 3, 2026, 6:11 AM
Protected: Cell and gene therapy patents: What’s accelerating, what’s lagging behind - Pharmaceutical Technology
Protected: Cell and gene therapy patents: What’s accelerating, what’s lagging behind  Pharmaceutical Technology
Google News
Jul 3, 2026, 4:54 AM
Huons completes merger to strengthen pharma, biotech businesses - ë§¤ěťĽę˛˝ě ś
Huons completes merger to strengthen pharma, biotech businessesÂ Â ë§¤ěťĽę˛˝ě ś
Google News
Jul 3, 2026, 4:20 AM
Fosun Pharma to invest $27.5 mil. in AriBio after AR1001 licensing deal - koreabiomed.com
Fosun Pharma to invest $27.5 mil. in AriBio after AR1001 licensing deal  koreabiomed.com
Google News
Jul 3, 2026, 3:12 AM
GEODIS Achieves IATA CEIV Pharma Certification in Hyderabad (India), Strengthening Commitment to Healthcare Logistics - India Shipping News
GEODIS Achieves IATA CEIV Pharma Certification in Hyderabad (India), Strengthening Commitment to Healthcare Logistics  India Shipping News
Google News
Jul 3, 2026, 2:25 AM
US Congress probes big pharma’s China trials, pushes FDA data ban - CHOSUNBIZ - Chosunbiz
US Congress probes big pharma’s China trials, pushes FDA data ban - CHOSUNBIZ  Chosunbiz
Google News
Jul 3, 2026, 2:02 AM
Patients and generics sector urge EU to react to Trump's drug pricing threats - Euractiv
Patients and generics sector urge EU to react to Trump's drug pricing threats  Euractiv
Google News
Jul 3, 2026, 1:53 AM
India's next pharmaceutical revolution | Hindustan Times - Hindustan Times
India's next pharmaceutical revolution | Hindustan Times  Hindustan Times
Google News
Jul 3, 2026, 1:28 AM
Pharma CEO, Daughter To Pay $2M In SEC Stock Fraud Case - Law360
Pharma CEO, Daughter To Pay $2M In SEC Stock Fraud Case  Law360
Sponsored placement
Featured promotions
Sponsored
Get Offer !0%
JeplusHealthcare.Pvt.Ltd